NCT06777290View on ClinicalTrials.gov

Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Lymphoma, Diffuse Large B-Cell
Trial Locations (1)

12808

Department of Radiology, General University Hospital in Prague, Prague, Czech Republic, Prague

All Listed Sponsors
collaborator

General University Hospital, Prague

OTHER

lead

Charles University, Czech Republic

OTHER

NCT06777290 - Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma | Biotech Hunter | Biotech Hunter